Healthcare Blogs | 3Gen Consulting Insights
Logo
Back
CompanyAboutOur Culture
Back
SolutionsRevenue Cycle Management ▸Medical Coding & HIM ▸Risk Adjustment & HEDIS ▸Consulting & Advisory ▸
Back
MarketPayers ▸Providers ▸Specialities ▸
Back
TechnologyMedical Coding Platform ▸Revenue Cycle Platform ▸Risk Adjustment Platform ▸
Back
ResourcesBlogsCase StudiesE-GuidesWhitepapersInfographicsNewslettersPress ReleaseVideosVoice Of Leadership
Back
Revenue Cycle ManagementPatient AccessMedical BillingAccounts ReceivableRevenue Integrity
Back
Medical Coding & HIMMedical CodingAudit & EducationClinical Documentation
Back
Risk Adjustment & HEDISRisk Adjustment CodingHEDIS Abstraction
Back
Consulting & Advisory Provider Enrollment & Credentialing Payer Contract Review & Fee NegotiationsHealthcare Management CounsultingRevenue Cycle AutomationHealthcare Data AnalyticsMACRA ConsultingMedical Writing
Back
PayersAccountable Care OrganizationsMedicare Advantage PlansPACE Programs
Back
ProvidersAmbulatory Surgery CentersClinical LaboratoriesFederally Qualified Health CentersH&H SystemsPhysician GroupsUrgent Care Centers
Back
SpecialitiesAnesthesiologyAutism Spectrum DisorderDurable Medical EquipmentGastroenterologyHome HealthHospiceOrthopedicPathologyPediatricRadiologyRemote Patient MonitoringTelemedicine
Back
CodeGen-i
Back
RevGen-i
Back
RiskGen-CoreRiskGen-i

Insights That Move Healthcare

Expert perspectives on revenue cycle, risk adjustment, compliance, and healthcare strategy – designed to help providers, plans, and leaders make smarter operational and financial decisions.

Preparing for CLFS Reimbursement Changes: Why...

Laboratory revenue cycle management encompasses every operational process connecting clinical laboratory services to collected Medicare reimbursement – and in August 2026, it has become the most actionable lever available to laboratory executives preparing for a confirmed payment shift. The Consolidated Appropriations Act, 2026, signed February 3, 2026, delayed all PAMA-related Clinical Laboratory Fee Schedule (CLFS) rate reductions through December 31, 2026 – the seventh Congressional intervention since PAMA was enacted [1]. But the reprieve is temporary.

Read Blog Post Read Blog Post
Laboratory revenue cycle management review of billing accuracy, denials, reimbursement trends, and 2027 CLFS readiness
providers:
Specialities:
Solutions:

No Data Found

No hits here… yet! Don’t worry – plenty of other resources await. Looking for something specific? Reach out and we’ll help you find it.

Explore our strategic insights & resources

Pathology Revenue Health Check
E-Guideread more
Laboratory revenue cycle management review of billing accuracy, denials, reimbursement trends, and 2027 CLFS readiness
Blogread more
alt Thumb edit
Infographicread more
View All ResourcesView All Resources
let's
talk